Immunocore Holdings plc Previous ETF Holding It
Immunocore Holdings plc (IMCR). 6 retained portfolio positions. Missing dates and values remain unreported.
- BBC: Fund Virtus Biotech Clinical Trials Etf; Added / first observed 2021-07-30.
- FFTY: Fund Innovator IBD(R) 50 ETF; Added / first observed 2024-01-31.
- FPXE: Fund First Trust IPOX Europe Equity Opportunities ETF; Added / first observed 2022-06-30.
- FPXI: Fund First Trust International Equity Opportunities ETF; Added / first observed 2022-12-30.
Previous ETF Holding It
6 retained portfolio positions. Missing dates and values remain unreported.
| ETF | Fund | Added / first observed | Removed / first absent |
|---|---|---|---|
| BBC | Virtus Biotech Clinical Trials Etf | 2021-07-30 | |
| FFTY | Innovator IBD(R) 50 ETF | 2024-01-31 | |
| FPXE | First Trust IPOX Europe Equity Opportunities ETF | 2022-06-30 | |
| FPXI | First Trust International Equity Opportunities ETF | 2022-12-30 | |
| FTLS | First Trust Long/Short Equity ETF | 2023-07-31 | |
| GINN | Goldman Sachs Innovate Equity ETF | 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |